Celldex Therapeutics Inc (CLDX)
36.96
-0.78
(-2.07%)
USD |
NASDAQ |
Apr 24, 16:00
37.01
+0.05
(+0.14%)
After-Hours: 20:00
Celldex Therapeutics Profit Margin (Quarterly): -1.05K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.05K% |
| September 30, 2023 | -2.52K% |
| June 30, 2023 | -11.38K% |
| March 31, 2023 | -3.04K% |
| December 31, 2022 | -1.64K% |
| September 30, 2022 | -6.58K% |
| June 30, 2022 | -22.09K% |
| March 31, 2022 | -13.25K% |
| December 31, 2021 | -6.03K% |
| September 30, 2021 | -13.37K% |
| June 30, 2021 | -384.3% |
| March 31, 2021 | -2.41K% |
| December 31, 2020 | -578.6% |
| September 30, 2020 | -2.13K% |
| June 30, 2020 | -4.67K% |
| March 31, 2020 | -462.8% |
| December 31, 2019 | -1.18K% |
| September 30, 2019 | -2.09K% |
| June 30, 2019 | -1.65K% |
| March 31, 2019 | -1.21K% |
| December 31, 2018 | -533.0% |
| September 30, 2018 | -769.7% |
| June 30, 2018 | -593.8% |
| March 31, 2018 | -2.90K% |
| December 31, 2017 | -111.1% |
| Date | Value |
|---|---|
| September 30, 2017 | -671.8% |
| June 30, 2017 | -746.0% |
| March 31, 2017 | -2.23K% |
| December 31, 2016 | -1.72K% |
| September 30, 2016 | -1.33K% |
| June 30, 2016 | -2.30K% |
| March 31, 2016 | -2.66K% |
| December 31, 2015 | -1.82K% |
| September 30, 2015 | -3.12K% |
| June 30, 2015 | -1.49K% |
| March 31, 2015 | -6.21K% |
| December 31, 2014 | -2.15K% |
| September 30, 2014 | -2.55K% |
| June 30, 2014 | -4.78K% |
| March 31, 2014 | -7.19K% |
| December 31, 2013 | -3.56K% |
| September 30, 2013 | -2.36K% |
| June 30, 2013 | -19.60K% |
| March 31, 2013 | -718.0% |
| December 31, 2012 | -460.8% |
| September 30, 2012 | -482.7% |
| June 30, 2012 | -685.6% |
| March 31, 2012 | -555.5% |
| December 31, 2011 | -523.1% |
| September 30, 2011 | -498.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-22.09K%
Minimum
Jun 2022
-384.3%
Maximum
Jun 2021
-5.08K%
Average
-2.41K%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| ThermoGenesis Holdings Inc | -291.5% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 12.23% |
| Xtant Medical Holdings Inc | -15.31% |
| Asensus Surgical Inc | -317.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.69% |
| Return on Assets | -41.05% |
| Return on Invested Capital | -44.69% |
| Operating Margin (Quarterly) | -850.3% |
| Return on Net Operating Assets | -399.9% |